Late Breaking Abstract - MicroRNA profiling informs on the pulmonary sequelae of COVID-19-induced ARDS

M. García Hidalgo (Lleida, Spain), I. Benítez (Lleida, Spain), M. Pérez-Pons (Lleida, Spain), J. González (Lleida, Spain), P. Carmona (Lleida, Spain), S. Santisteve (Lleida, Spain), C. Gort-Paniello (Lleida, Spain), A. Moncusí-Moix (Lleida, Spain), F. Rodríguez-Jara (Lleida, Spain), M. Molinero (Lleida, Spain), G. Torres (Lleida, Spain), J. Bermejo-Martín (Salamanca, Spain), A. Ceccato (Madrid, Spain), L. Fernández-Barat (Barcelona, Spain), R. Ferrer (Barcelona, Spain), D. García-Casulla (Barcelona, Spain), R. Menéndez (Valencia, Spain), A. Motos (Barcelona, Spain), Ó. Peñuelas (Getafe, Spain), J. Riera (Barcelona, Spain), A. Torres (Barcelona, Spain), F. Barbé (Lleida, Spain), D. De Gonzalo-Calvo (Lleida, Spain)

Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Session: Late breaking basic and translational science of SARS-Cov2 and COVID-19
Session type: Oral Presentation
Number: 4116

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. García Hidalgo (Lleida, Spain), I. Benítez (Lleida, Spain), M. Pérez-Pons (Lleida, Spain), J. González (Lleida, Spain), P. Carmona (Lleida, Spain), S. Santisteve (Lleida, Spain), C. Gort-Paniello (Lleida, Spain), A. Moncusí-Moix (Lleida, Spain), F. Rodríguez-Jara (Lleida, Spain), M. Molinero (Lleida, Spain), G. Torres (Lleida, Spain), J. Bermejo-Martín (Salamanca, Spain), A. Ceccato (Madrid, Spain), L. Fernández-Barat (Barcelona, Spain), R. Ferrer (Barcelona, Spain), D. García-Casulla (Barcelona, Spain), R. Menéndez (Valencia, Spain), A. Motos (Barcelona, Spain), Ó. Peñuelas (Getafe, Spain), J. Riera (Barcelona, Spain), A. Torres (Barcelona, Spain), F. Barbé (Lleida, Spain), D. De Gonzalo-Calvo (Lleida, Spain). Late Breaking Abstract - MicroRNA profiling informs on the pulmonary sequelae of COVID-19-induced ARDS. 4116

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021


Late Breaking Abstract - Recurrent Neural Networks and environmental data for COPD exacerbation prediction
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020


Late Breaking Abstract - MicroRNA signatures in critically ill COVID-19 patients: a bronchial aspirate study
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021



Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018




Late Breaking Abstract - Protein signature stratifies severity of chronic lung disease in preterms after birth
Source: International Congress 2018 – Prematurity and lung disease
Year: 2018

Late Breaking Abstract - Capnography for ultimately simple diagnostics of COPD
Source: International Congress 2017 – Innovation in COPD: techniques and facts
Year: 2017



Late Breaking Abstract - Fully automated airway measurement correlates with radiological disease progression in Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2021 – Remote monitoring of respiratory patients
Year: 2021



Late Breaking Abstract - Acute multi-organ symptoms predict long COVID
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021


Late Breaking Abstract - Improving management of acute hypercapnic respiratory failure with Non-Invasive Ventilation
Source: International Congress 2019 – Current trends in noninvasive ventilation for chronic respiratory failure
Year: 2019



Late Breaking Abstract - Pulmonary embolism in patients admitted by COVID-19. Incidence and features.
Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension
Year: 2020




Late Breaking Abstract - Effects of pulmonary rehabilitation on major symptoms of long COVID (post-COVID-19 syndrome): preliminary results
Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases
Year: 2021


Late Breaking Abstract - Assessment of disease progression in IPF patients using Functional Respiratory Imaging (FRI)
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017



Late Breaking Abstract - Relationship between obesity and aging of the pulmonary parenchyma
Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease
Year: 2020


Late Breaking Abstract: Expression of S100A4 in COPD
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010

Late Breaking Abstract - Lung deflation with Indacaterol/Glycopyrronium improves cardiac function in COPD patients: The CLAIM Study
Source: International Congress 2017 – Update and new perspectives in Airway Diseases
Year: 2017

Late Breaking Abstract - Validation of a tool for the assessment of disease awareness (DA) in COPD
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017


Late Breaking Abstract - Increased risk of pulmonary embolism in patients with radiological severe COVID-19 pneumonia
Source: Virtual Congress 2020 – COVID-19 clinical studies
Year: 2020


Late Breaking Abstract - Organoids and lung-on-chip to study SARS-CoV-2-mediated lung injury
Source: Virtual Congress 2020 – Covering COVID - the best abstracts
Year: 2020




Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020


Late Breaking Abstract - Pulmonary embolism in patients with COVID-19: Time to change thromboprophylaxis paradigm.
Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension
Year: 2020